(R)-6-(4-chlorophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one

ID: ALA5268658

Max Phase: Preclinical

Molecular Formula: C11H11ClN2O

Molecular Weight: 222.68

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H]1CC(=O)NN=C1c1ccc(Cl)cc1

Standard InChI:  InChI=1S/C11H11ClN2O/c1-7-6-10(15)13-14-11(7)8-2-4-9(12)5-3-8/h2-5,7H,6H2,1H3,(H,13,15)/t7-/m1/s1

Standard InChI Key:  VECYAKYVLADWSP-SSDOTTSWSA-N

Molfile:  

 
     RDKit          2D

 15 16  0  0  0  0  0  0  0  0999 V2000
   14.8163  -28.3978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8152  -29.2228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5278  -29.6345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2423  -29.2224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2394  -28.3942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5260  -27.9863    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9516  -27.9826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6655  -28.3934    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3741  -27.9829    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3752  -27.1600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6615  -26.7491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9466  -27.1612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0877  -26.7486    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.2331  -26.7520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1025  -29.6336    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  5  7  1  0
 10 13  2  0
 12 14  1  6
  2 15  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5268658

    ---

Associated Targets(Human)

SK-MEL3 (228 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A498 (42825 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IMR-90 (216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 222.68Molecular Weight (Monoisotopic): 222.0560AlogP: 2.20#Rotatable Bonds: 1
Polar Surface Area: 41.46Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.79CX Basic pKa: 0.91CX LogP: 2.15CX LogD: 2.15
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.78Np Likeness Score: -0.70

References

1. Lewis TA, de Waal L, Wu X, Youngsaye W, Wengner A, Kopitz C, Lange M, Gradl S, Ellermann M, Lienau P, Schreiber SL, Greulich H, Meyerson M..  (2019)  Optimization of PDE3A Modulators for SLFN12-Dependent Cancer Cell Killing.,  10  (11): [PMID:31749907] [10.1021/acsmedchemlett.9b00360]

Source